CMS Takes the Reins: The Big Shake-Up in Medicare Drug Pricing

CMS announced the 10 Medicare Part D medications slated for pricing negotiations next year, on which Medicare enrollees spent a staggering $3.4 billion in out-of-pocket expenses in 2022. CMS has not been able to negotiate drug prices as other countries do, thanks to the Medicare Modernization Act of 2003. Now, the recently signed Inflation Reduction Act (2022) allows…

Read More

The Science of Focus

As SaaS sales leaders, we aren’t exactly scientists, but in many cases we need to lead with data. With that in mind, it’s valuable to unpack what the science says about Focus: The message is clear: focus is not just a “nice to have” for productivity – it’s a scientifically proven difference maker. Strategically designing…

Read More

The Unbundling: Is Blue Shield’s Big Move a PBM Game-Changer?

Blue Shield of California announced a new cost-saving drug prescription model that involves cutting ties with CVS Health’s Caremark pharmacy benefit manager—one of the largest PBMs in the U.S. This news received a lot of attention, specifically around the “disruption” of PBMs. CVS’s stock subsequently plummeted, prompting the question: Is this the beginning of the end for…

Read More

Safe Space Adds Key Benefit with HireFor Partnership

In the dynamic landscape of talent acquisition, finding the right individuals to join your team is a journey that demands time, effort, and resources. That’s where HireFor steps in to revolutionize your hiring process, making it not only efficient but also effective.  “It was a no-brainer to work with HireFor after seeing how many People…

Read More

Not All Tasks Are Created Equal

As we discussed last week, the Eisenhower Matrix is a great tool for identifying tasks that are ideal to handoff. As a rule of thumb, any tasks that are urgent but not important (Quadrant 3), and not reliant on your specific skills, are prime for delegation. For most sales leaders, this includes general administrative tasks,…

Read More

The Wild West of Digital Health

The digital health space has become the “Wild West”: thousands of digital health companies have launched during the pandemic, with many touting improved healthcare outcomes and increased return on investment without sufficient evidence. Who knows which solutions actually work and which ones don’t? As we enter the post-pandemic era, purchasers will need to reevaluate their digital health…

Read More